课题基金 / 基金详情

Elucidation of protumor/antitumor immune regulation mechanisms based on host versus cancer stem cell responses

Elucidation of protumor/antitumor immune regulation mechanisms based on host versus cancer stem cell responses
基于宿主与癌症干细胞反应阐明促肿瘤/抗肿瘤免疫调节机制
批准号:
22300331
负责人:
NISHIMURA Takashi
金额:
$10.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

NISHIMURA Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the present research, we investigated the mechanisms of protumor immune regulation in tumor microenvironment. As a result, we found that 〓 〓T cells were predominant IL-17-producing cells in tumor-bearing host, which promoted tumorigenesis through the angiogenesis. In addition, we demonstrated that the tumor-initiating capacity of CD133^+ cells was blocked by depleting Treg, which were induced in TGF-ss-dependent manner, suggesting that CD133^+ cancer initiating cells suppress CTL-mediated immunosurveillance. In the near future, overcoming the protumor immunity caused by cancer stem cells, which induces effective tumor-antigen specific Th1 cells, would be a promising strategy for cancer immunotherapy and prevention of recurrence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.intimp.2010.11.026
发表时间: 2011-02
期刊: International immunopharmacology
影响因子: 5.6
作者: [Sachi Tanaka;S. Koizumi;K. Masuko;N. Makiuchi;Y. Aoyagi;E. Quivy;R. Mitamura;Tsutomu Kano;T. Ohkuri;D. Wakita;K. Chamoto;H. Kitamura;T. Nishimura]
通讯作者: Sachi Tanaka;S. Koizumi;K. Masuko;N. Makiuchi;Y. Aoyagi;E. Quivy;R. Mitamura;Tsutomu Kano;T. Ohkuri;D. Wakita;K. Chamoto;H. Kitamura;T. Nishimura
Helper/killer hybrid epitope long peptide(H/K-HELP) as a novel tool for cancer vaccine therapy
辅助/杀伤杂合表位长肽(H/K-HELP)作为癌症疫苗治疗的新工具
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Takahashi Y, Sakurai M, Murakami Y, et al.(11著者中、最終著者), 上田龍三, 西村孝司]
通讯作者: 西村孝司
がん特異的免疫治療の進歩と細胞治療の問題点
癌症特异性免疫治疗的进展和细胞治疗的问题
DOI: --
发表时间: 2011
期刊: 腫瘍内科
影响因子: --
作者: [Kakimi K, Isobe M, Uenaka A, Wada H, Sato E, Doki Y, Nakajima J, Seto Y, Yamatsuji T, Naomoto Y, Shiraishi K, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Oka M, Pan L, Hoffman EW, Old LJ, Nakayama E, Suzuki S, 西村孝司]
通讯作者: 西村孝司
The extract of Japanese soybean, Kurosengoku activates the production of IL-12 and IFN-γ byDC or NK1.1(+) cells in a TLR4-andTLR2-dependent manner
日本大豆提取物黑五谷以 TLR4 和 TLR2 依赖性方式激活 DC 或 NK1.1(+) 细胞产生 IL-12 和 IFN-γ
DOI: 10.1016/j.cellimm.2010.09.009
发表时间: 2011
期刊: Cell Immunol
影响因子: 4.3
作者: [Tanaka S, Koizumi S, Makiuchi N, Aoyagi Y, Quivy E, Mitamura R, Kano T, Wakita D, Chamoto K, Kitamura H, Nishimura T]
通讯作者: Nishimura T
44
    New Development of Singularity Theory
    • 批准号:
      17K05245
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2017
    • 负责人:
      NISHIMURA Takashi
    • 依托单位:
    Adaptive strategies and regulatory mechanisms for body growth and metabolism in response to changes in the nutritional environment
    • 批准号:
      17H03658
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2017
    • 负责人:
      NISHIMURA Takashi
    • 依托单位:
    Theoretical and empirical research on social capital formation in strategic human resource management
    • 批准号:
      17K03937
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2017
    • 负责人:
      NISHIMURA Takashi
    • 依托单位:
    Geometric integration of crystal theory and vision theory by singularity theory
    • 批准号:
      26610035
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.91万
    • 财政年份:
      2014
    • 负责人:
      NISHIMURA Takashi
    • 依托单位:
    国内基金
    海外基金
    KIF4A通过激活IL-17/NF-κB信号通路促进三阴性乳腺癌恶性进展的机制研究
    基于PI3K/AKT/Th17/IL-17调控炎症微环境探讨肺复方改善肺癌免疫治疗应答的临床及机制研究
    SPP1⁺巨噬细胞通过IL-8-EMT样转化-IL-17环路与滑膜成纤维细胞互作驱动类风湿关节炎难治性表型的机制研究
    • 批准号:
      2026JJ50588
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李芬
    • 依托单位:
    IL-17失衡通过衰老T细胞来源的淋巴毒素驱动肾脏异位淋巴组织慢性炎症的机制
    • 批准号:
      JCZRLH202600547
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: